Document Detail


Mobilization of peripheral blood progenitor cells by hematopoietic growth factors.
MedLine Citation:
PMID:  8853524     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The anti-tumor effect and toxicity of chemotherapeutic agents are dose-related. The dose-response curve for these agents is sigmoidal with a threshold, a lag phase, a linear phase and a plateau phase. The aim of cancer chemotherapy is to exploit the difference between the response curves for the tumor and normal tissues. In the laboratory and in some animal models, the dose-response curve for many agents demonstrates a log-linear relationship between dose and cell kill so that a doubling of the drug dose may increase cell kill by ten-fold. The more effective a drug is, the steeper the dose-response curve. Dose may be an important variable in the outcome of therapy, however, this dose-response relationship has been difficult to demonstrate because a dose-response effect may not be evident for most human tumors in the dose ranges used in clinical trials.
Authors:
N J Chao
Related Documents :
24714604 - Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel...
23383014 - Pencilbeam irradiation technique for whole brain radiotherapy: technical and biological...
6616444 - Dose-response study of n-nitrosoproline formation in rats and a deduced kinetic model f...
1428094 - Species differences in carcinogen metabolism and interspecies extrapolation.
1362614 - The effect of pertussis toxin treatment on alpha-1-adrenoceptor-mediated pressor respon...
16435474 - Cholinergic secretory and inhibitory mechanisms in canine pancreatic secretion.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Canadian journal of oncology     Volume:  5 Suppl 1     ISSN:  1183-2509     ISO Abbreviation:  Can J Oncol     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1996-12-24     Completed Date:  1996-12-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9305916     Medline TA:  Can J Oncol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  43-6     Citation Subset:  IM    
Affiliation:
Department of Medicine, Stanford University Medical Center, CA 94305, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / administration & dosage,  adverse effects,  therapeutic use*
Cell Death
Clinical Trials as Topic
Disease Models, Animal
Dose-Response Relationship, Drug
Hematopoietic Cell Growth Factors / administration & dosage,  therapeutic use*
Hematopoietic Stem Cells / drug effects*
Humans
Linear Models
Neoplasms / drug therapy
Treatment Outcome
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Hematopoietic Cell Growth Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical trial design in metastatic breast cancer: a commentary.
Next Document:  Health-related quality of life as a treatment endpoint in metastatic breast cancer.